Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.


TSXV:COV - Post by User

Bullboard Posts
Comment by bada123bingon Aug 21, 2012 9:22am
109 Views
Post# 20240978

RE: Covalon Announces FDA Clearance for SurgiClear

RE: Covalon Announces FDA Clearance for SurgiClear
 1. SurgiClear combines the comfort of skin-friendly silicone adhesive     technology with the advanced antimicrobial protection of two     gold-standard antimicrobial agents - chlorhexidine and silver.  2. SurgiClear has uniquely bonded the two antimicrobials into the     actual adhesive of the soft and non-sensitizing silicone that     allows the clear film wound dressing to comfortably adhere to the     skin while providing antimicrobial protection.  3. SurgiClear kills over 99.99% of bacteria that come into contact     with the dressing's antimicrobial adhesive and prevents the     re-growth of bacteria on patient's skin over 7 days of wear.  4. SurgiClear is breathable unlike most other silicone dressings.  5. Patients are able to bathe while wearing the waterproof silicone     SurgiClear wound dressing.  6. Studies have shown that SurgiClear is up to ten times less painful     on removal than leading film dressings that use acrylic adhesives.  7. Studies have shown that the use over a 14-day period of silicone     similar to SurgiClear prevents keloid and hypertrophic scarring     following surgical procedures.
Bullboard Posts